Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Transducer Mechanism: Enzyme-Linked Receptors

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

Adrenergic Receptors: ɑ Subtype

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...

Pancreatic Juice and Secretion

Pancreatic Juice and Secretion

Pancreatic juice is a clear fluid produced by the pancreas, containing water, salts, sodium bicarbonate, and enzymes vital for digestion in the small intestine. It helps break down large molecules, facilitating nutrient absorption.
When acidic chyme from the stomach enters the duodenum, it triggers the release of secretin, a hormone that prompts pancreatic juice secretion. After a fatty meal, cholecystokinin, another hormone, stimulates gallbladder contraction and enhances enzyme-rich...

Glucagon-like Receptor Agonists

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Mass screening for colorectal cancer: are we ready?

JAMA·1989

Same author

Lowered cost potential for hepatitis B vaccine.

JAMA·1985

Same author

Landmark perspective: Bertram W. Sippy and ulcer disease therapy.

JAMA·1983

Same author

The use and abuse of endoscopic retrograde cholangiopancreatography.

JAMA·1983

Same author

A history lesson: hepatitis is not always what it seems.

JAMA·1982

Same author

Images and reflections.

JAMA·1981

Same journal

WHO Issues Guidelines for Treating Ebola and Marburg Viruses.

JAMA·2026

Same journal

FDA Approves Additional Naloxone Nasal Spray for Opioid Overdose.

JAMA·2026

Same journal

HIV May Hide in More Cells Than Previously Thought-Here's What That Could Mean for a Cure.

JAMA·2026

Same journal

US Dietary Supplement Use Increasing, Especially in Older Adults.

JAMA·2026

Same journal

Heat Stress From Climate Change Surges Globally.

JAMA·2026

Same journal

Strength Training Linked With Lower Cardiovascular Disease Risk in Women.

JAMA·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 26, 2026

Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve

Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve

Published on: June 14, 2017

The prostaglandins.

|August 25, 1975

Summary

This summary is machine-generated.

Dinoprost tromethamine (Prostin F2 Alpha) is an effective second-trimester abortifacient, superior to saline. While side effects occur, experience improves outcomes for this prostaglandin therapy.

More Related Videos

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Published on: April 7, 2023

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader

Published on: May 24, 2024

Related Experiment Videos

Last Updated: Jun 26, 2026

Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve

Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve

Published on: June 14, 2017

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Published on: April 7, 2023

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader

Published on: May 24, 2024

Area of Science:

Obstetrics and Gynecology
Pharmacology

Background:

Prostaglandins, like dinoprost tromethamine, have diverse clinical applications beyond their natural roles.
Dinoprost tromethamine (Prostin F2 Alpha) was the first prostaglandin used clinically as an abortifacient in the second trimester.

Purpose of the Study:

To evaluate the efficacy and safety of dinoprost tromethamine for second-trimester abortion.
To compare dinoprost tromethamine with hypertonic saline for intra-amniotic instillation.

Main Methods:

Intra-amniotic administration of dinoprost tromethamine in the United States.
Clinical observation of patient responses and adverse reactions.

Main Results:

Dinoprost tromethamine is effective and relatively safe, outperforming hypertonic saline.
Adverse reactions include allergic responses, hypertension, bronchospasm, gastrointestinal distress, and uterine hyperstimulation.
Uterine hyperstimulation can lead to cervical laceration, lower uterine segment rupture, retained placenta, and hemorrhage.

Conclusions:

Dinoprost tromethamine is a superior option for second-trimester abortion compared to hypertonic saline.
Improved clinical experience with dinoprost tromethamine administration enhances therapeutic outcomes and reduces adverse effects.